Biotech

News, research & analysis from the global Biotechnology industry.

August 31, 2017

The CAR-T Revolution: Gilead’s $12B Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies

[vc_row][vc_column][vc_column_text] Gilead Sciences has ended its M&A moratorium with an $11.9B all-cash acquisition of CAR-T Cell Therapy pioneers Kite Pharma. Kite’s leading drug Axi-Cel is expected […]
August 22, 2017

Exploring the History & Viability of Xenotransplantation: Porcine Retroviruses, CRISPR Off-Target Effects, Immune Rejection & Regulatory Hurdles

[vc_row][vc_column][vc_column_text]Scientists at e-Genesis, a Massachusetts-based biotech firm, recently announced that they have successfully utilised CRISPR gene-editing technology to inactivate Porcine Endogenous Retroviruses (PERVs) in a line […]
May 23, 2017

Thermo Fisher Continues Vertical Integration with $7.2B Acquisition of CDMO Patheon

[vc_row][vc_column][vc_column_text] Dutch Contract Development & Manufacturing Organisation Patheon has been acquired by Thermo Fisher Scientific in a $7.2B deal. The acquisition, which includes the assumption of […]